Sep 4, 2026 06:44AM

Sep 3, 2026 04:03PM

Sep 3, 2026 03:52PM

Aug 20, 2026 07:00AM

Aug 20, 2026 07:00AM

Jul 29, 2026 07:05AM

Jul 29, 2026 07:05AM Ionis announces Dr. Frank Bennett, chief scientific officer, to retire

Jul 29, 2026 07:00AM

Jul 23, 2026 07:11AM

Jul 14, 2026 09:16AM

Jul 14, 2026 09:16AM

Jul 13, 2026 07:01AM

Jul 13, 2026 07:00AM

Jul 6, 2026 07:00AM Ionis completes enrollment in Phase 3 Angelman syndrome study

Jul 6, 2026 07:00AM

Jun 25, 2026 07:12AM

Jun 25, 2026 06:48AM

Jun 25, 2026 03:33AM

Jun 25, 2026 02:59AM

Jun 25, 2026 02:59AM

Jun 24, 2026 02:39PM FDA approves Ionis drug Tryngolza for severe hypertriglyceridemia

Jun 24, 2026 02:37PM

Jun 4, 2026 07:00AM

Jun 1, 2026 06:57AM

May 28, 2026 04:45AM

May 14, 2026 07:05AM

May 14, 2026 07:05AM

Apr 29, 2026 07:00AM Ionis reports first quarter 2026 financial results and highlights progress on key programs

Apr 28, 2026 02:06AM

Apr 28, 2026 02:06AM

Apr 21, 2026 07:03AM

Apr 21, 2026 07:00AM

Mar 30, 2026 07:30AM

Mar 30, 2026 07:30AM

Mar 23, 2026 07:00AM FDA grants priority review to Ionis' Alexander disease treatment

Mar 23, 2026 07:00AM

Mar 9, 2026 07:00AM

Mar 9, 2026 07:00AM

Mar 5, 2026 07:30AM

Feb 26, 2026 07:00AM

Feb 26, 2026 07:00AM

Feb 26, 2026 07:00AM Olezarsen sNDA accepted by the FDA for Priority Review for the treatment of severe hypertriglyceridemia (sHTG)

Feb 25, 2026 01:20PM

Feb 25, 2026 07:00AM

Feb 4, 2026 07:30AM

Feb 4, 2026 07:30AM

Jan 21, 2026 07:00AM

Jan 21, 2026 07:00AM

Jan 12, 2026 11:06AM BIOGEN receives EU approval for high dose SPINRAZA for spinal muscular atrophy

Jan 12, 2026 11:05AM

330,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All